Page 4 - Prospective Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data-Driven Insights To Improve Your Recruitment Process For Clinical Trials By Michael Gebauer and Andreas Krämer Globally, approximately $186 billion was spent on drug discovery in 2019, 1 with nearly 50 percent of that spent on clinical trials. 2 One of the major challenges in this regard is the recruitment of suitable patients, 3,4 who are sometimes driven by negative attitudes or a lack of education and information about clinical trials in general. 5 However, robust data based on representative research are rare. For example, Trauth et al. (2000) report a willingness to participate of 46 percent (n=489 in the U.S. state of Pennsylvania). 6 A CISCRP study reported a basic willingness to participate of more than 80 percent,

United kingdomUnited statesNordrhein westfalenMichael gebauerBreite unterstSiteworks gmbUniversity of bonnMental healthPhrma annual membershipStrategic consultingSiteworks gmbhMembership surveyProspective evaluationCancer clinical trial accrual patternsIdentifying potential barriersClinical oncology